Experience

Davis Polk advised the joint book-running managers and the initial purchasers in a Rule 144A/Regulation S offering of $550 million principal amount of 3.000% senior secured notes due…

Davis Polk advised the initial purchaser in connection with a Rule 144A offering by Bloom Energy Corporation of $200 million aggregate principal amount of its 2.500% green convertible…

Davis Polk advised the initial purchasers on a Rule 144A and Regulation S reopening of $50 million aggregate principal amount of 7.500% senior secured notes due 2028 of AI Candelaria …

Davis Polk advised Freeline Therapeutics Holdings plc on its $158.8 million initial public offering of 8,823,529 American depositary shares representing 8,823,529 ordinary shares, which…

Davis Polk advised the representatives of the underwriters in connection with an approximately $963.5 million public offering of ordinary shares of Horizon Therapeutics Public Limited…

Davis Polk advised the sole bookrunning manager on an SEC-registered offering by Schlumberger Investment SA of $350 million aggregate principal amount of 2.650% senior notes due 2030. The…

Davis Polk advised the representatives of the several underwriters in connection with a debut SEC-registered bond offering by ServiceNow, Inc. of $1.5 billion aggregate principal amount of…

Davis Polk is advising StoneCo Ltd. on its agreement for STNE Participações S.A., a controlled company of Stone that holds the software investments business of the Stone group in …

Davis Polk advised Acutus Medical, Inc. on its SEC-registered initial public offering of 10,147,058 shares of common stock for an aggregate price to the public of approximately $170 million…

Davis Polk advised the underwriters on the registered offering of $700 million aggregate principal amount of 1.100% notes due 2030 and $300 million aggregate principal amount of 2.000%…